Home › Funds › IRIDIAN ASSET MANAGEMENT LLC/CT › NKTR

IRIDIAN ASSET MANAGEMENT LLC/CT position in NKTR

NEKTAR THERAPEUTICS · Health Care

IRIDIAN ASSET MANAGEMENT LLC/CT reported holding 94,697 shares of NKTR (NEKTAR THERAPEUTICS) in its Q3 2026 13F filing — a position valued at US$5.7M, representing 2.09% of its reported portfolio and ranking #13 among its reported holdings. IRIDIAN ASSET MANAGEMENT LLC/CT has disclosed NKTR holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)94.70K sh
Reported value held$5.73M
Portfolio Weight2.09%
First reportedQ4 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How IRIDIAN ASSET MANAGEMENT LLC/CT's NKTR position evolved

IRIDIAN ASSET MANAGEMENT LLC/CT first disclosed a stake in NKTR in Q4 2025 at 9,728 shares (US$411K). The position peaked in Q3 2026 at 94,697 shares, worth US$5.7M. Across 4 filings, IRIDIAN ASSET MANAGEMENT LLC/CT increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 94,697 shares valued at US$5.7M — an increase of 55,895 shares quarter over quarter.. Notable position changes include a 222% increase in Q1 2026 (shares fell 3% over the following quarter), a 144% increase in Q3 2026 (shares fell 38% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 9.73K $411.30K New
Q1 2026 31.32K $2.25M Add
Q2 2026 38.80K $2.71M Add
Q3 2026 94.70K $5.73M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NKTR and 13F data

NKTR (NEKTAR THERAPEUTICS) is a Health Care company. 58 other funds we track also report a position in NKTR — the largest reported positions include Two Seas Capital LP (US$202.6M), BVF INC/IL (US$166.9M), Vestal Point Capital, LP (US$69.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NKTR

All NKTR fund holders →

FAQ

How long has IRIDIAN ASSET MANAGEMENT LLC/CT held NKTR?

IRIDIAN ASSET MANAGEMENT LLC/CT has disclosed NKTR holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is IRIDIAN ASSET MANAGEMENT LLC/CT's current position in NKTR?

As of Q3 2026, IRIDIAN ASSET MANAGEMENT LLC/CT holds 94.70K shares of NKTR (NEKTAR THERAPEUTICS), valued at $5.73M, representing 2.09% of its reported portfolio and ranking #13.

Has IRIDIAN ASSET MANAGEMENT LLC/CT been buying or selling NKTR?

In the latest 13F filing (Q3 2026), IRIDIAN ASSET MANAGEMENT LLC/CT increased its position in NKTR. The position peaked in Q3 2026 at 94.70K shares.

Which other funds hold NKTR?

Other major institutional holders of NKTR include Two Seas Capital LP, BVF INC/IL, Vestal Point Capital, LP, among 58 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.